Susanna Brauner

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: NEUROEPIDEMIOLOGY. 2024;:1-10

Long-Term Healthcare Resource Utilization and Costs among Patients with Myasthenia Gravis: A Swedish Nationwide Population-Based Study

Cai Q; Batista AE; Borsum J; Zhang Q; Isheden G; Kunovszki P; Gandhi K; Heerlein K; Brauner S
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2024;31(1):e16100

Pregnancy outcomes for women with myasthenia gravis and their newborns: A nationwide register-based cohort study

O'Connor L; Malmestrom C; Rodrigues RDS; Brauner S; Wikstrom A-K; Punga AR
Article: JAMA NEUROLOGY. 2022;79(11):1105-1112

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis The RINOMAX Randomized Clinical Trial

Piehl F; Eriksson-Dufva A; Budzianowska A; Feresiadou A; Hansson W; Hietala MA; Hakansson I; Johansson R; Jons D; Kmezic I; Lindberg C; Lindh J; Lundin F; Nygren I; Punga AR; Press R; Samuelsson K; Sundstrom P; Wickberg O; Brauner S; Frisell T
Article: NEUROLOGY. 2021;97(14):e1382-e1391

Patient-Reported Symptom Severity in a Nationwide Myasthenia Gravis Cohort Cross-sectional Analysis of the Swedish GEMG Study

Petersson M; Feresiadou A; Jons D; Ilinca A; Lundin F; Johansson R; Budzianowska A; Roos A-K; Kagstrom V; Gunnarsson M; Sundstrom P; Piehl F; Brauner S
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:667336

Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations

Creary LE; Gangavarapu S; Caillier SJ; Cavalcante P; Frangiamore R; Lie BA; Bengtsson M; Harbo HF; Brauner S; Hollenbach JA; Oksenberg JR; Bernasconi P; Maniaol AH; Hammarstrom L; Mantegazza R; Fernandez-Vina MA
Article: JAMA NEUROLOGY. 2020;77(8):974-981

Comparison Between Rituximab Treatment for New-Onset Generalized Myasthenia Gravis and Refractory Generalized Myasthenia Gravis

Brauner S; Eriksson-Dufva A; Hietala MA; Frisell T; Press R; Piehl F
Article: JOURNAL OF CLINICAL INVESTIGATION. 2020;130(2):838-852

C-type lectin receptors Mcl and Mincle contro development of multiple sclerosis like neuroinflammation

N'diaye M; Brauner S; Flytzani S; Kular L; Warnecke A; Adzemovic MZ; Piket E; Min J-H; Edwards W; Mela F; Choi HY; Magg V; James T; Linden M; Reichardt HM; Daws MR; van Horssen J; Kockum I; Harris RA; Olsson T; Guerreiro-Cacais AO; Jagodic M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2018;194(3):315-326

The Sjogren's syndrome-associated autoantigen Ro52/TRIM21 modulates follicular B cell homeostasis and immunoglobulin production

Brauner S; Ivanchenko M; Thorlacius GE; Ambrosi A; Wahren-Herlenius M
Article: CARDIOVASCULAR RESEARCH. 2018;114(1):158-167

Augmented Th17 differentiation in Trim21 deficiency promotes a stable phenotype of atherosclerotic plaques with high collagen content

Brauner S; Jiang X; Thorlacius GE; Lundberg AM; Ostberg T; Yan Z-Q; Kuchroo VK; Hansson GK; Wahren-Herlenius M
Article: BIOLOGY OF SEX DIFFERENCES. 2017;8(1):34

Sex influences eQTL effects of SLE and Sjogren's syndrome-associated genetic polymorphisms

Linden M; Sepulveda JIR; James T; Thorlacius GE; Brauner S; Gomez-Cabrero D; Olsson T; Kockum I; Wahren-Herlenius M
Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(10):1755-1763

H1N1 vaccination in Sjogren's syndrome triggers polyclonal B cell activation and promotes autoantibody production

Brauner S; Folkersen L; Kvarnstrom M; Meisgen S; Petersen S; Franzen-Malmros M; Mofors J; Brokstad KA; Klareskog L; Jonsson R; Westerberg LS; Trollmo C; Malmstrom V; Ambrosi A; Kuchroo VK; Nordmark G; Wahren-Herlenius M
Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):139

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)

Oke V; Brauner S; Larsson A; Gustafsson J; Zickert A; Gunnarsson I; Svenungsson E
Article: BIOLOGY OF SEX DIFFERENCES. 2017;8:16

Difference in clinical presentation between women and men in incident primary Sjogren's syndrome

Sepulveda JIR; Kvarnstrom M; Brauner S; Baldini C; Wahren-Herlenius M
Article: JOURNAL OF INTERNAL MEDICINE. 2015;278(3):323-332

Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease

Brauner S; Zhou W; Backlin C; Green TM; Folkersen L; Ivanchenko M; Lofstrom B; Xu-Monette ZY; Young KH; Pedersen LM; Moller MB; Sundstrom C; Enblad G; Baecklund E; Wahren-Herlenius M
Article: MULTIPLE SCLEROSIS JOURNAL. 2014;20(13):1727-1736

Interferon beta treatment of multiple sclerosis increases serum interleukin-7

Lundstrom W; Hermanrud C; Sjostrand M; Brauner S; Wahren-Herlenius M; Olsson T; Karrenbauer V; Hillert J; Fogdell-Hahn A
Article: JOURNAL OF IMMUNOLOGY. 2013;191(7):3753-3763

Expression of the Immune Regulator Tripartite-Motif 21 Is Controlled by IFN Regulatory Factors

Sjostrand M; Ambrosi A; Brauner S; Sullivan J; Malin S; Kuchroo VK; Espinosa A; Wahren-Herlenius M
Article: JOURNAL OF EXPERIMENTAL MEDICINE. 2009;206(8):1661-1671

Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway

Espinosa A; Dardalhon V; Brauner S; Ambrosi A; Higgs R; Quintana FJ; Sjostrand M; Eloranta M-L; Gabhann JN; Winqvist O; Sundelin B; Jefferies CA; Rozell B; Kuchroo VK; Wahren-Herlenius M
Article: LUPUS. 2007;16(1):10-17

Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun

Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
Article: JOURNAL OF IMMUNOLOGY. 2006;176(10):6277-6285

The Sjogren's syndrome-associated autoantigen Ro52 is an E3 ligase that regulates proliferation and cell death

Espinosa A; Zhou W; Ek M; Hedlund M; Brauner S; Popovic K; Horvath L; Wallerskog T; Oukka M; Nyberg F; Kuchroo VK; Wahren-Herlenius M
Article: MOLECULAR IMMUNOLOGY. 2006;43(6):588-598

Structural, functional and immunologic characterization of folded subdomains in the Ro52, protein targeted in Sjogren's syndrome

Ottosson L; Hennig J; Espinosa A; Brauner S; Wahren-Herlenius M; Sunnerhagen M

Alla övriga publikationer

Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(12):1840-1842

Clinical associations and expression pattern of the autoimmunity susceptibility factor DIORA-1 in patients with primary Sjogren's syndrome

Aqrawi LA; Mentlein L; Meneghel L; Bjork A; Thorlacius GE; Ivanchenko M; Sepulveda JIR; Skarstein K; Kvarnstrom M; Brauner S; Espinosa A; Wahren-Herlenius M
Letter: EXPERIMENTAL DERMATOLOGY. 2017;26(5):444-446

IL-22 binding protein regulates murine skin inflammation

Lindahl H; Martini E; Brauner S; Nikamo P; Serezal IG; Guerreiro-Cacais AO; Jagodic M; Eidsmo L; Stahle M; Olsson T
Thesis / dissertation: 2013

TRIM21/ Ro52 in B cell pathology

Brauner, Susanna
Letter: JOURNAL OF IMMUNOLOGY. 2009;183(12):7620-7621

Comment on "Gene Disruption Study Reveals a Nonredundant Role for TRIM21/Ro52 in NF-κB-Dependent Cytokine Expression in Fibroblasts Response

Espinosa A; Brauner S; Ambrosi A; Kuchroo V; Wahren-Herlenius M

Anställningar

Senior Forskningsspecialist, Klinisk neurovetenskap, Karolinska Institutet, 2022-

Examina och utbildning

Docent, Experimentell neurologi, Karolinska Institutet, 2023
Medicine Doktorsexamen, Institutionen för medicin, Solna, Karolinska Institutet, 2013
Läkarexamen, Karolinska Institutet, 2007

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI